Polyglutamine homopolymers having 8-45 residues form slablike β-crystallite assemblies

Proteins: Structure, Function and Genetics

Volumn 61, Issue 2, 2005, Pages 398-411

  Sharma, Deepak ^a   Shinchuk, Leonid M ^a,c   Inouye, Hideyo ^a   Wetzel, Ronald ^b   Kirschner, Daniel A ^a  

^a BOSTON COLLEGE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

crystallite; helix; Amyloid; Huntington's disease; X ray diffraction

Indexed keywords

AMYLOID BETA PROTEIN; POLYGLUTAMINE; POLYPEPTIDE; SYNTHETIC PEPTIDE;

ARTICLE; DEGENERATIVE DISEASE; ENERGY; HUNTINGTON CHOREA; MOLECULAR MODEL; NEUROLOGIC DISEASE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; STEREOCHEMISTRY; STRUCTURE ANALYSIS; X RAY POWDER DIFFRACTION;

AMINO ACIDS; DNA REPEAT EXPANSION; MODELS, MOLECULAR; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; X-RAY DIFFRACTION;

EID: 26444575834     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.20602     Document Type: Article

References (87)

1. Cummings CJ, Zoghbi HY. Fourteen and counting: Unraveling trinucleotide repeat diseases. Hum Mol Genet 2000;9:909-916.
2. Bates GP, Benn C. The polyglutamine diseases. In: Bates GP, Harper PS, Jones L, editors. Huntington's disease. Oxford, UK: Oxford University Press; 2002. p 429-472.
3. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000;23:217-247.
4. Zoghbi HY, Orr HT. Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol 1999;9:566-570.
5. Michalik A, Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 2003;12(Suppl 2):R173-R186.
6. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003;361:1642-1644.
7. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004;431:805-810.
8. Martin JB. Molecular basis of the neurodegenerative disorders [published erratum]. N Engl J Med 1999;340:1970-1980.
9. Paulson HL. Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold. Am J Hum Genet 1999;64:339-345.
10. Kaytor MD, Warren ST. Aberrant protein deposition and neurological disease. J Biol Chem 1999;274:37507-37510.
11. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 2002;296:1991-1995.
12. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice, A, Mandel J-L. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995; 378:403-406.
13. Bennett MJ, Huey-Tubman KE, Herr AB, West AP Jr, Ross SA, Bjorkman PJ. A linear lattice model for poly-glutamine in CAG expansion diseases. Proc Natl Acad Sci USA 2002;99:11634-11639.
14. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci USA 1999;96:4604-4609.
15. Chen S, Ferrone F, Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci USA 2002;99:11884-11889.
16. Masino L, Pastore A. Glutamine repeats: structural hypotheses and neurodegeneration. Biochem Soc Trans 2002;30:548-551.
17. Perutz MF, Staden R, Moens L, DeBaere I. Polar zippers. Curr Biol 1993;3:249-253.
18. Lathrop RH, Casale M, Tobias DJ, Marsh JL, Thompson LM. Modeling protein homopolymeric repeats: possible polyglutamine structural motifs for Huntington's disease. Proc Int Conf Intell Syst Mol Biol 1998;6:105-114.
19. Thakur AK, Wetzel R. Mutational analysis of the structural organization of polyglutamine aggregates. Proc Natl Acad Sci USA 2002;99:17014-17019.
20. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994;91:5355-5358.
21. Altschuler EL, Hud NV, Mazrimas JA, Rupp B. Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. J Pept Res 1997;50:73-75.
22. Sharma D, Sharma S, Pasha S, Brahmachari SK. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions. FEBS Lett 1999;456:181-185.
23. Chen S, Wetzel R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci 2001;10:887-891.
24. Chen S, Berthelier V, Yang W, Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol 2001;311:173-182.
25. Perutz MF, Finch JT, Berriman J, Lesk A. Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci USA 2002;99:5591-5595.
26. Perutz MF, Pope BJ, Owen D, Wanker EE, Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques. Proc Natl Acad Sci USA 2002;99:5596-5600.
27. Inouye H, Kirschner DA. Alzheimer's β amyloid: insights into fibril formation and structure from Congo red binding. In: Harris JR, Fahrenholz F, editors. Alzheimer's disease: cellular and molecular aspects of amyloid. Series: Subcellular Biochemistry, Vol. 38. New York: Springer-Verlag; 2005. p 203-224.
28. Wetzel R. Protein folding and aggregation in the expanded polyglutamine repeat diseases. In: Buchner J, Kiefhaber T, editors. The protein folding handbook. New York: Wiley; 2004. p 1170-1214.
29. Oldenbourg R, Phillips WC. Small permanent magnet for fields up to 2.6 T. Rev Sci Instr 1986;57:2362-2365.
30. Glucksman MJ, Hay RD, Makowski L. X-ray diffraction from magnetically oriented solutions of macromolecular assemblies. Science 1986;231:1273-1276.
31. Pauling L. Diamagnetic anisotropy of the peptide group. Proc Natl Acad Sci USA 1979;76:2293-2294.
32. Worcester DL. Structural origins of diamagnetic anisotropy in proteins. Proc Natl Acad Sci USA 1978;75:5475-5477.
33. Graf DL. Crystallographic tables for the rhombohedral carbonates. Am Mineralogist 1961;46:1283-1316.
34. Inouye H, Karthigasan J, Kirschner DA. Membrane structure in isolated and intact myelins. Biophys J 1989;56:129-137.
35. Inouye H, Fraser PE, Kirschner DA. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: analysis by X-ray diffraction. Biophys J 1993;64:502-519.
36. Inouye H, Kirschner DA. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative α-helices. J Mol Biol 1997;268:375-389.
37. Guex N, Diemand A, Peitsch MC. Protein modelling for all. Trends Biochem Sci 1999;24:364-367.
38. McRee DE. "XtalView/Xfit"-a versatile program for manipulating atomic coordinates and electron density. J Struct Biol 1999;125: 156-165.
39. Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph 1990;8:52-56.
40. Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 1991;24: 946-950.
41. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995;20:374-376.
42. Sikorski P, Atkins E. New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils. Biomacromolecules 2005;6:425-432.
43. Inouye H, Bond J, Baldwin MA, Ball HL, Prusiner SB, Kirschner DA. Structural changes in a hydrophobic domain of the prion protein induced by hydration and by Ala→Val and Pro→Leu substitutions. J Mol Biol 2000;300:1285-1298.
44. Vainshtein BK. Diffraction of X-rays by chain molecules. Amsterdam: Elsevier; 1966. 414 p.
45. Sc. Fibre Diffraction Rev 2003;11:102-112.
46. Inouye H. X-ray scattering from a discrete helix with cumulative angular and translational disorders. Acta Crystallogr A 1994;50: 644-646.
47. Starikov EB, Lehrach, Wanker E. Folding of oligoglutamines: a theoretical approach based upon thermodynamics and molecular mechanics. J Biomol Struct Dyn 1999;17:409-427.
48. Ross CA, Poirier MA, Wanker EE, Amzel M. Polyglutamine fibrillogenesis: the pathway unfolds. Proc Natl Acad Sci USA 2003;100:1-3.
49. Goux WJ, Kopplin L, Nguyen AD, Leak K, Rutkofsky M, Shanmuganandam VD, Sharma D, Inouye H, Kirschner DA. Twisted and straight filaments formed from short segments of tau protein lacking β-turn regions. J Biol Chem 2004;279:26868-26875.
50. Inouye H, Kirschner DA. Refined fibril structures: the hydrophobic core in Alzheimer's amyloid β-protein and prion as revealed by X-ray diffraction. In: Bock GR, Goode JA, editors. Nature and origin of amyloid fibrils. CIBA Foundation Symposium No. 199. Chichester, UK: Wiley; 1996. p 22-39.
51. Tjernberg LO, Tjernberg A, Bark N, Shi Y, Ruzsicska BP, Bu ZM, Thyberg J, Callaway DJE. Assembling amyloid fibrils from designed structures containing a significant amyloid β-peptide fragment. Biochem J 2002;366:343-351.
52. Reches M, Gazit E. Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments. Amyloid 2004;11:81-89.
53. Reches M, Porat Y, Gazit E. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem 2002;277:35475-35480.
54. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 2002;16:77-83.
55. Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 2005;102:315-320.
56. Stanger HE, Syud FA, Espinosa JF, Giriat I, Muir T, Gellman SH. Length-dependent stability and strand length limits in antiparallel β-sheet secondary structure. Proc Natl Acad Sci USA 2001;98: 12015-12020.
57. Monoi H, Futaki S, Kugimiya H, Minakata H, Yoshihara K. Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine disease. Biophys J 2000;78:2892-2899.
58. Blake C, Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix. Structure 1996;4:989-998.
59. Malinchik SB, Inouye H, Szumowski KE, Kirschner DA. Structural analysis of Alzheimer's β(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys J 1998;74:537-545.
60. Bond JP, Deverin SP, Inouye H, El-Agnaf OM, Teeter MM, Kirschner DA. Assemblies of Alzheimer's peptides Aβ25-35 and Aβ31-35: reverse-turn conformation and side-chain interactions revealed by X-ray diffraction. J Struc Biol 2003;141:156-170.
61. Makin OS, Serpell LC. The structure of amyloid. Fibre Diffraction Rev 2004;12:29-35.
62. Tycko R. Insights into the amyloid folding problem from solid-state NMR. Biochemistry 2003;42:3151-3159.
63. Silva RAGD, Barber-Armstrong W, Decatur SM. The organization and assembly of a β-sheet formed by a prion peptide in solution: an isotope-edited FTIR study. J Am Chem Soc 2003;125:13674-13675.
64. Sokolowski F, Modler AJ, Masuch R, Zirwer D, Baier M, Lutsch G, Moss DA, Gast K, Naumann D. Formation of critical oligomers is a key event during conformational transition of recombinant Syrian hamster prion protein. J Biol Chem 2003;278:40481-40492.
65. McColl IH, Blanch EW, Gill AC, Rhie AGO, Ritchie MA, Hecht L, Nielsen K, Barren LD. A new perspective on β-sheet structures using vibrational Raman optical activity: From poly(L-lysine) to the prion protein. J Am Chem Soc 2003;125:10019-10026.
66. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Aggregation and secondary structure of synthetic amyloid β A4 peptides of Alzheimer's disease. J Mol Biol 1991;218:149-163.
67. Fraser PE, Nguyen JT, Inouye H, Surewicz WK, Selkoe DJ, Podlisny MB, Kirschner DA. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry 1992;31:10716-10723.
68. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils. Proc Natl Acad Sci USA 2000;97:13045-13050.
69. Lynn DG, Meredith SC. Review: model peptides and the physicochemical approach to β-amyloids. J Struct Biol 2000;130:153-173.
70. Torok M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R. Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem 2002;277:40810- 40815.
71. Ma B, Nussinov R. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16-22, Aβ16-35, and Aβ10-35): sequence effects. Proc Natl Acad Sci USA 2002;99:14126-14131.
72. Shivaprasad S, Wetzel R. An intersheet packing interaction in Aβ fibrils mapped by disulfide crosslinking. Biochemistry 2004;43: 15310-15317.
73. Nguyen JT, Inouye H, Baldwin MA, Fletterick R, Cohen FE, Prusiner SB, Kirschner DA. X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol 1995;252:412-422.
74. Shmueli U, Traub W. An X-ray diffraction study of poly-L-lysine hydrochloride. J Mol Biol 1965;12:205-214.
75. Padden FJ Jr, Keith HD, Giannoni G. Single crystals of poly-L-lysine. Biopolymers 1969;7:793-804.
76. DeMarco ML, Daggett V. From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci USA 2004;101:2293-2298.
77. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, Cohen FE, Agard DA, Prusiner SB. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 2002;99:3563-3568.
78. Govaerts C, Wille H, Prusiner SB, Cohen FE. Evidence for assembly of prions with left-handed β-helices into trimers. Proc Natl Acad Sci USA 2004;101:8342-8347.
79. Bevivino AE, Loll PJ. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel β-fibrils. Proc Natl Acad Sci USA 2001;98:11955-11960.
80. Kajava AV, Baxa U, Wickner RB, Steven AC. A model for Ure2p prion filaments and other amyloids: the parallel superpleated β-structure. Proc Natl Acad Sci USA 2004;101:7885-7890.
81. Inouye H, Bond JE, Deverin SP, Lim A, Costello CE, Kirschner DA. Molecular organization of amyloid protofilament-like assembly of betabellin 15D: Helical array of β-sandwiches. Biophys J 2002;83:1716-1727.
82. Aravinda S, Harini W, Shamala N, Das C, Balaram P. Structure and assembly of designed β-hairpin peptides in crystals as models for β-sheet aggregation. Biochemistry 2004;43:1832-1846.
83. Pauling L, Corey RB. Configurations of polypeptide chains with favored orientations around single bonds: two new pleated sheets. Proc Natl Acad Sci USA 1951;37:729-740.
84. Arnott S, Dover D, Elliott A. Structure of β-poly-L-alanine: refined atomic co-ordinates for an anti-parallel β-pleated sheet. J Mol Biol 1967;30:201-208.
85. Fraser RDB, MacRae TP, Parry DAD, Suzuki E. The structure of β-keratin. Polymer 1969;10:810-826.
86. Cochran W, Crick FHC, Vand V. The structure of synthetic polypeptides: I. The transform of atoms on a helix. Acta Crystallogr 1952;5:581-586.
87. Franklin RE, Klug A. The splitting of layer lines in X-ray fibre diagrams of helical structures: application to tobacco mosaic virus. Acta Crystallogr 1955;8:777-780.